ReviewAmerican journal of translational research2024
The relationship between small for gestational age infants and maternal health: a meta-analysis.
Review in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Placental transport dysfunction in omega-3 and omega-6 fatty acid in patients with gestational diabetes mellitus.Annals of medicine · 2026Article
- Application of artificial intelligence in diagnosis and management of fetal growth disorders: a comprehensive review.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFetal growth restriction, commonly referred to as small for gestational age (SGA) in academic contexts, is associated with increased mortality rates and significant health risks. Fetal development is influenced by a complex interplay of maternal factors, fetal characteristics, and placenta fiction. This meta-analysis explored the relationship between the prevalence of SGA infants and various maternal conditions, such as overall health, lifestyle choices, and underlying medical conditions.
methodsA comprehensive literature search on maternal factor and SGA was conducted in PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang, and China Biology Medicine (CBM) (SinoMed) databases from 2000 to 2022. The Cochrane Collaboration tool was adopted to assess the quality of the selected literature. STATA 14.0 software was used to perform the statistical analysis and graphic presentation. Meta-analysis was registered with International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY) (202410045).
resultsIn total, 15 studies with 41,446 infants identified as being SGA were included in this Meta-analysis. SGA occurrence was not associated with maternal age or multi-parameter, but was related to abnormal Body Mass Index (BMI) (RR=2.23, 95% CI [1.24, 4.00]). Smoking was strongly associated with SGA (RR=3.09, 95% CI [1.53, 6.23]), while drinking was not. SGA was negatively correlated with pregestational diabetes (RR=0.59, 95% CI [0.40, 0.88]) and pregnancy complications, including gestational diabetes (RR=0.74, 95% CI [0.56, 0.97]), hypertension (RR=2.84, 95% CI [1.88, 4.29]) and preeclampsia (RR=2.38, 95% CI [1.77, 3.20]).
conclusionsMaternal risk factors, including BMI, smoking, pregestational diabetes, gestational diabetes, gestational hypertension, and preeclampsia, are associated with SGA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.